TABLE 5.
Multivariate analysis of risk factors associated with 6‐week mortality; all patients included
| Risk factor | p‐Value | OR | 95% CI |
|---|---|---|---|
| Rebleeding | <0.0001 | 2.69 | 1.82–3.98 |
| Age >80 | 0.53 | 1.15 | 0.74–1.78 |
| Female sex | 0.82 | 0.95 | 0.64–1.42 |
| BMI <20 or >30 | 0.17 | 1.30 | 0.89–1.89 |
| NSAIDs/aspirin/steroids use | 0.71 | 0.93 | 0.64–1.35 |
| Oral anticoagulant | 0.89 | 0.97 | 0.60–1.56 |
| Alcohol >30 g/day | 0.66 | 0.90 | 0.55–1.45 |
| Smoking | 0.63 | 1.11 | 0.72–1.73 |
| Cirrhosis | 0.05 | 1.62 | 1.00–2.62 |
| Charlson score >3 | 0.002 | 1.81 | 1.24–2.65 |
| Haemodynamic instability | <0.0001 | 2.30 | 1.45–3.67 |
| GBS >11 | 0.48 | 1.16 | 0.77–1.76 |
| Pre‐RS >5 | 0.018 | 1.65 | 1.82–2.51 |
| Active bleeding | 0.310 | 1.22 | 0.74–1.78 |
| Haemoglobin <8 g/dl | 0.166 | 1.30 | 0.64–1.89 |
| In‐patients | <0.0001 | 2.71 | 0.90–3.88 |
Note: Those were the risk factors having a significant p value concerning the association with mortality.
Abbreviations: BMI, body mass index; CI, confidence interval; GBS, Glasgow‐Blatchford score; NSAIDs, non‐steroidal anti‐inflammatory drugs; Pre‐RS, pre‐endoscopic Rockall score; OR, odds ratio.